Log in to save to my catalogue

Extended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in malian children: 24...

Extended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in malian children: 24...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1459403986

Extended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in malian children: 24-month follow-up of a randomized, double-blinded phase 2 trial

About this item

Full title

Extended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in malian children: 24-month follow-up of a randomized, double-blinded phase 2 trial

Publisher

United States: Public Library of Science

Journal title

PloS one, 2013-11, Vol.8 (11), p.e79323-e79323

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

The FMP2.1/AS02A candidate malaria vaccine was tested in a Phase 2 study in Mali. Based on results from the first eight months of follow-up, the vaccine appeared well-tolerated and immunogenic. It had no significant efficacy based on the primary endpoint, clinical malaria, but marginal efficacy against clinical malaria in secondary analyses, and hi...

Alternative Titles

Full title

Extended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in malian children: 24-month follow-up of a randomized, double-blinded phase 2 trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1459403986

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1459403986

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0079323

How to access this item